Does fresh frozen plasma (FFP) contain von Willebrand factor (VWF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fresh Frozen Plasma Contains von Willebrand Factor

Yes, fresh frozen plasma (FFP) contains von Willebrand factor (VWF) as part of its soluble coagulation factor content. According to the AAGBI blood transfusion guidelines, FFP contains all the factors of the soluble coagulation system, including the labile factors V and VIII to a varying degree 1.

Composition of Fresh Frozen Plasma

Fresh frozen plasma is leucodepleted plasma that is rapidly frozen to below -25°C to maintain the integrity of labile coagulation factors. It contains:

  • All soluble coagulation factors
  • Labile factors V and VIII
  • von Willebrand factor
  • Fibrinogen (approximately 2g in four units of FFP)
  • Other plasma proteins

Comparison with Cryoprecipitate

While FFP does contain VWF, it's important to note that cryoprecipitate contains a more concentrated amount of VWF. The AAGBI guidelines specifically state that cryoprecipitate is a "leucodepleted plasma product containing concentrated factor VIII, von Willebrand factor, fibrinogen, factor XIII and fibronectin, produced by further processing of FFP" 1.

This means that:

  • FFP contains VWF, but in lower concentrations
  • Cryoprecipitate contains a more concentrated form of VWF
  • For clinical situations requiring significant VWF replacement, cryoprecipitate may be more effective

Clinical Relevance

The presence of VWF in FFP has important clinical implications:

  • In patients with thrombotic thrombocytopenic purpura (TTP), FFP infusions can provide the VWF-cleaving protease (ADAMTS13) that is deficient in these patients 2
  • In von Willebrand disease, while FFP contains VWF, research suggests that cryoprecipitate achieves higher increases in VWF levels compared to FFP 3
  • Studies have shown that FFP can affect VWF multimeric forms in patients with chronic relapsing TTP 4

Important Considerations

When using FFP for its VWF content:

  • The recommended therapeutic dose of FFP is 15 ml/kg 1
  • FFP should be ABO compatible with the recipient
  • If blood group is unknown, group AB FFP is preferred as it doesn't contain anti-A or anti-B antibodies
  • FFP can be thawed using a dry oven (10 min), microwave (2-3 min), or water bath (20 min)
  • Once thawed, FFP can be used for up to 24 hours if stored at 4°C (extended to 5 days for major hemorrhage associated with trauma)
  • Once out of the refrigerator, it must be used within 30 minutes

For patients specifically requiring VWF replacement (such as those with von Willebrand disease), cryoprecipitate or specific factor concentrates may be more appropriate than FFP due to their higher concentration of VWF 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.